Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007 | Original Article

Polymeric Formula Has Direct Anti-Inflammatory Effects on Enterocytes in an in VitroModel of Intestinal Inflammation

Authors: Naomi S. H. de Jong, Steven T. Leach, Andrew S. Day

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

Exclusive enteral nutrition using polymeric formula (PF) is a well-established therapeutic option for active Crohn’s disease; however, its mechanisms of action are unknown. We investigated the anti-inflammatory effects of PF in an in vitro model of epithelial cell inflammation. PF did not affect cell viability over a range of dilutions, but when PF was added to the culture medium the interleukin (IL)-8 response to proinflammatory stimuli was significantly reduced. This effect was due to PF acting directly on the cells as the IL-8 response was still reduced when PF was separated from the proinflammatory stimuli in a 2-compartment system. In the presence of PF, nuclear factor (NF)-κB nuclear migration was not inhibited; however, IκBα degradation was delayed. PF has direct anti-inflammatory effects upon immortalized colonic enterocytes. Therefore PF may, in part, modulate gut inflammation by directly reducing the inflammatory response of the intestinal epithelium.
Literature
1.
go back to reference Binder V (2004) Epidemiology of IBD during the twentieth century: an integrated view. Baillieres Best Pract Res Clin Gastroenterol 18:463–479CrossRef Binder V (2004) Epidemiology of IBD during the twentieth century: an integrated view. Baillieres Best Pract Res Clin Gastroenterol 18:463–479CrossRef
2.
go back to reference Kim SC, Ferry GD (2004) Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 126:1550–1560PubMedCrossRef Kim SC, Ferry GD (2004) Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 126:1550–1560PubMedCrossRef
3.
go back to reference Phavichitr N, Cameron DJ, Catto-Smith AG (2003) Increasing incidence of Crohn’s disease in Victorian children. J Gastroenterol Hepatol 18:329–332PubMedCrossRef Phavichitr N, Cameron DJ, Catto-Smith AG (2003) Increasing incidence of Crohn’s disease in Victorian children. J Gastroenterol Hepatol 18:329–332PubMedCrossRef
4.
go back to reference Schmidt C, Stallmach A (2005) Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol 51:127–145PubMed Schmidt C, Stallmach A (2005) Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol 51:127–145PubMed
5.
go back to reference Lissauer T, Clayden G (2004) Gastroenterology. In: Illustrated textbook of paediatrics. Mosby, St. Louis, pp 182–183 Lissauer T, Clayden G (2004) Gastroenterology. In: Illustrated textbook of paediatrics. Mosby, St. Louis, pp 182–183
6.
go back to reference Griffiths AM (2004) Specificities of inflammatory bowel disease in childhood. Baillieres Best Pract Res Clin Gastroenterol 18:509–523CrossRef Griffiths AM (2004) Specificities of inflammatory bowel disease in childhood. Baillieres Best Pract Res Clin Gastroenterol 18:509–523CrossRef
7.
go back to reference Goh J, O’Morain CA (2003) Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 17:307–320PubMedCrossRef Goh J, O’Morain CA (2003) Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 17:307–320PubMedCrossRef
8.
go back to reference Thomas AG, Taylor F, Miller V (1993) Dietary intake and nutritional treatment in childhood Crohn’s disease. J Pediatr Gastroenterol Nutr 17:75–81PubMedCrossRef Thomas AG, Taylor F, Miller V (1993) Dietary intake and nutritional treatment in childhood Crohn’s disease. J Pediatr Gastroenterol Nutr 17:75–81PubMedCrossRef
9.
go back to reference Heuschkel RB, Menache CC, Megerian JT, Baird AE (2000) Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 31:8–15PubMedCrossRef Heuschkel RB, Menache CC, Megerian JT, Baird AE (2000) Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 31:8–15PubMedCrossRef
10.
go back to reference Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK (1994) Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 19:175–180PubMedCrossRef Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK (1994) Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr 19:175–180PubMedCrossRef
11.
go back to reference Lochs H, Steinhardt HJ, Klaus-Wentz B, Zeitz M, Vogelsang H, Sommer H, Fleig WE, Bauer P, Schirrmeister J, Malchow H (1991) Comparison of enteral nutrition and drug treatment in active Crohn’s disease. Results of the European Cooperative Crohn’s Disease Study. IV. Gastroenterology 101:881–888PubMed Lochs H, Steinhardt HJ, Klaus-Wentz B, Zeitz M, Vogelsang H, Sommer H, Fleig WE, Bauer P, Schirrmeister J, Malchow H (1991) Comparison of enteral nutrition and drug treatment in active Crohn’s disease. Results of the European Cooperative Crohn’s Disease Study. IV. Gastroenterology 101:881–888PubMed
12.
go back to reference Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H, Jarnum S, Brandes JW, Leonhardt H, Ewe K (1990) Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn’s disease. European Cooperative Crohn’s Disease Study III. Scand J Gastroenterol 25:235–244PubMed Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H, Jarnum S, Brandes JW, Leonhardt H, Ewe K (1990) Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn’s disease. European Cooperative Crohn’s Disease Study III. Scand J Gastroenterol 25:235–244PubMed
13.
go back to reference O’Morain C, Segal AW, Levi AJ (1984) Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Br Med J 1859–1862 O’Morain C, Segal AW, Levi AJ (1984) Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Br Med J 1859–1862
14.
go back to reference Zoli G, Care M, Parazza M, Spano C, Biagi PL, Bernardi M, Gasbarrini G (1997) A randomized controlled study comparing elemental diet and steroid treatment in Crohn’s disease. Aliment Pharmacol Ther 11:735–740PubMedCrossRef Zoli G, Care M, Parazza M, Spano C, Biagi PL, Bernardi M, Gasbarrini G (1997) A randomized controlled study comparing elemental diet and steroid treatment in Crohn’s disease. Aliment Pharmacol Ther 11:735–740PubMedCrossRef
15.
go back to reference Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD (2004) Exclusive enteral nutrition as primary therapy in children with Crohn’s disease. J Gastroenterol Hepatol 19:A277 Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD (2004) Exclusive enteral nutrition as primary therapy in children with Crohn’s disease. J Gastroenterol Hepatol 19:A277
16.
go back to reference Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 108:1056–1067PubMedCrossRef Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 108:1056–1067PubMedCrossRef
17.
go back to reference Verma S, Brown S, Kirkwood B, Giaffer MH (2000) Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double-blind trial. Am J Gastroenterol 95:735–739PubMedCrossRef Verma S, Brown S, Kirkwood B, Giaffer MH (2000) Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double-blind trial. Am J Gastroenterol 95:735–739PubMedCrossRef
18.
go back to reference Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B (2004) Elemental versus polymeric enteral nutrition in paediatric Crohn’s disease: a multicentre randomized controlled trial. Acta Paediatr 93:327–335PubMedCrossRef Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B (2004) Elemental versus polymeric enteral nutrition in paediatric Crohn’s disease: a multicentre randomized controlled trial. Acta Paediatr 93:327–335PubMedCrossRef
19.
go back to reference Beattie RM, Bentsen BS, MacDonald TT (1998) Childhood Crohn’s disease and the efficacy of enteral diets. Nutrition 14:345–350PubMedCrossRef Beattie RM, Bentsen BS, MacDonald TT (1998) Childhood Crohn’s disease and the efficacy of enteral diets. Nutrition 14:345–350PubMedCrossRef
20.
go back to reference Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT (1994) Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455–1466PubMed Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT (1994) Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455–1466PubMed
21.
go back to reference Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, Donnet-Hughes A, MacDonald TT, Walker-Smith JA (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther 14:281–289PubMedCrossRef Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, Donnet-Hughes A, MacDonald TT, Walker-Smith JA (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther 14:281–289PubMedCrossRef
22.
go back to reference Breese EJ, Michie CA, Nicholls SW, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT (1995) The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment Pharmacol Ther 9:547–552PubMedCrossRef Breese EJ, Michie CA, Nicholls SW, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT (1995) The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn’s disease. Aliment Pharmacol Ther 9:547–552PubMedCrossRef
23.
go back to reference Ferguson A, Glen M, Ghosh S (1998) Crohn’s disease: nutrition and nutritional therapy. Baillieres Clin Gastroenterol 12:93–114PubMedCrossRef Ferguson A, Glen M, Ghosh S (1998) Crohn’s disease: nutrition and nutritional therapy. Baillieres Clin Gastroenterol 12:93–114PubMedCrossRef
24.
go back to reference Meister D, Bode J, Shand A, Ghosh S (2002) Anti-inflammatory effects of enteral diet components on Crohn’s disease-affected tissues in vitro. Dig Liver Dis 34:430–438PubMedCrossRef Meister D, Bode J, Shand A, Ghosh S (2002) Anti-inflammatory effects of enteral diet components on Crohn’s disease-affected tissues in vitro. Dig Liver Dis 34:430–438PubMedCrossRef
25.
go back to reference Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, Morelli L (2005) Enteral nutrition and microflora in pediatric Crohn’s disease. J Parenter Enteral Nutr 29:S173–S178CrossRef Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, Morelli L (2005) Enteral nutrition and microflora in pediatric Crohn’s disease. J Parenter Enteral Nutr 29:S173–S178CrossRef
26.
go back to reference Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D (2000) Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6:205–214PubMed Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D (2000) Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6:205–214PubMed
27.
go back to reference Sartor RB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92:5S–11SPubMed Sartor RB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92:5S–11SPubMed
28.
go back to reference Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847–855PubMed Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847–855PubMed
29.
go back to reference Chang EB, Sitirin MD, Black DD (1996) Gastrointestinal, hepatobiliary, and nutritional physiology. Philadelphia: Lippincott-Raven Chang EB, Sitirin MD, Black DD (1996) Gastrointestinal, hepatobiliary, and nutritional physiology. Philadelphia: Lippincott-Raven
30.
go back to reference Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477–484PubMedCrossRef Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477–484PubMedCrossRef
31.
go back to reference Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290PubMedCrossRef Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290PubMedCrossRef
33.
go back to reference Baldwin ASJ (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649–683PubMedCrossRef Baldwin ASJ (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649–683PubMedCrossRef
34.
go back to reference Oz HS, Ray M, Chen TS, McClain CJ (2004) Efficacy of a transforming growth factor beta 2 containing nutritional support formula in a murine model of inflammatory bowel disease. J Am Coll Nutr 23:220–226PubMed Oz HS, Ray M, Chen TS, McClain CJ (2004) Efficacy of a transforming growth factor beta 2 containing nutritional support formula in a murine model of inflammatory bowel disease. J Am Coll Nutr 23:220–226PubMed
35.
go back to reference Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Habr-Gama A, Kiss DR (2002) Inflammatory bowel diseases: principles of nutritional therapy. Rev Hosp Clin Fac Med Sao Paulo 57:187–198PubMed Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Habr-Gama A, Kiss DR (2002) Inflammatory bowel diseases: principles of nutritional therapy. Rev Hosp Clin Fac Med Sao Paulo 57:187–198PubMed
36.
go back to reference Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90:770–774PubMedCrossRef Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90:770–774PubMedCrossRef
37.
go back to reference Dignass AU, Podolsky DK (1993) Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105:1323–1332PubMed Dignass AU, Podolsky DK (1993) Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 105:1323–1332PubMed
38.
go back to reference Planchon SM, Martins CA, Guerrant RL, Roche JK (1994) Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 153:5730–5739PubMed Planchon SM, Martins CA, Guerrant RL, Roche JK (1994) Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 153:5730–5739PubMed
39.
go back to reference Kutuk O, Basaga H (2004) Aspirin inhibits TNFalpha- and IL-1–induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine 25:229–237PubMedCrossRef Kutuk O, Basaga H (2004) Aspirin inhibits TNFalpha- and IL-1–induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine 25:229–237PubMedCrossRef
Metadata
Title
Polymeric Formula Has Direct Anti-Inflammatory Effects on Enterocytes in an in VitroModel of Intestinal Inflammation
Authors
Naomi S. H. de Jong
Steven T. Leach
Andrew S. Day
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9449-x

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.